Oder Investment Management’s Pfizer PFE Stock Holding History

Oder Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,686	Closed	-$509K	–	93
2023 Q4	$509K	Sell	17,686 -1,999	-10%	-$60.4K	0.5%	63
2023 Q3	$653K	Sell	19,685 -799	-4%	-$28.3K	0.71%	46
2023 Q2	$751K	Sell	20,484 -27,192	-57%	-$1.06M	0.82%	32
2023 Q1	$1.95M	Sell	47,676 -545	-1%	-$23.5K	2.28%	13
2022 Q4	$2.47M	Sell	48,221 -920	-2%	-$44.1K	3.07%	6
2022 Q3	$2.15M	Sell	49,141 -2,992	-6%	-$145K	2.52%	12
2022 Q2	$2.73M	Buy	52,133 +682	+1%	+$34.8K	3.36%	7
2022 Q1	$2.66M	Buy	51,451 +1,105	+2%	+$57.3K	3.03%	8
2021 Q4	$2.97M	Buy	50,346 +380	+0.8%	+$18.8K	4.19%	6
2021 Q3	$2.15M	Sell	49,966 -15,368	-24%	-$681K	3.15%	9
2021 Q2	$2.56M	Buy	65,334 +18	+0%	+$700	3.34%	6
2021 Q1	$2.37M	Buy	65,316 +9,182	+16%	+$326K	3.23%	7
2020 Q4	$2.07M	Buy	+56,134	New	+$2.06M	2.03%	13

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Oder Investment Management's PFE Position: Q1 2024 in Review

Oder Investment Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 17,686 shares — an estimated $509K sold.

Oder Investment Management first reported a position in PFE in Q4 2020 and held it in 13 quarters. The position peaked at $2.97M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Oder Investment Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Oder Investment Management sold 17,686 Pfizer shares in Q1 2024, an estimated $509K.
Oder Investment Management first reported a position in Pfizer in Q4 2020 and held it in 13 quarters.
Oder Investment Management's Pfizer position peaked at $2.97M in Q4 2021.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Oder Investment Management's 13F filing for Q1 2024, filed 10 May 2024.